Clinical Trials Directory

Trials / Completed

CompletedNCT00720213

Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device

Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Philips Respironics · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study is being undertaken to collect data from Respironics Inc's BiPAP Auto Servo Ventilation 3 (autoSV3) and compare with data from Respironics, Inc's BiPAP autoSV2, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Complex Sleep Apneas (Comp SAS) no worse than its predecessor, the BiPAP auto Servo ventilation 2 (autoSV2) device. This will be determined using a comparative, randomized design with the participants blinded to the therapy. Additionally, attempts will be made to blind the central scorer(s) with respect to which device is in use.

Detailed description

This study was conducted to evaluate the therapeutic performance of a new auto Servo Ventilation device (Philips Respironics autoSV Advanced) for the treatment of complex central sleep apnea (CompSA). The features of autoSV Advanced include an automatic expiratory pressure (EPAP) adjustment, an advanced algorithm for distinguishing open versus obstructed airway apnea, a modified auto backup rate which is proportional to subject's baseline breathing rate, and a variable inspiratory support. Our primary aim was to compare the performance of the advanced servo-ventilator (BiPAP autoSV Advanced) with conventional servo-ventilator (BiPAP autoSV) in treating central sleep apnea (CSA). Study Design: A prospective, multicenter, randomized, controlled trial. Setting: Five sleep laboratories in the United States. Participants: Thirty-seven participants were included.

Conditions

Interventions

TypeNameDescription
DEVICERespironics BiPAP autoSV2Respironics BiPAP autoSV2 is an Auto Servo Ventilation Device. This will be used on a randomized night.
DEVICERespironics BiPAP autoSV3Respironics BiPAP autoSV3 is an Auto Servo Ventilation Device. This will be used on a randomized night.

Timeline

Start date
2008-08-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2008-07-22
Last updated
2019-01-29
Results posted
2019-01-29

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00720213. Inclusion in this directory is not an endorsement.

Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device (NCT00720213) · Clinical Trials Directory